• About us
    • About us
    • Board of Directors
    • Leadership team and Scientific Consultants
    • Strategic Advisory Board (SAB) and Advisors for Commercialization
  • THAC’s pipeline
    • First-in-class drug candidates
    • Promising medical value of THAC drug candidates
    • Publications
  • T2DM pandemics
    • T2DM, a pandemics with still huge unmet medical needs
    • Microbiota, a key role in T2DM
    • Insulin resistance, the root cause of T2DM
  • News
  • Contact us
  • Home
  • About us
    • About us
    • Board of Directors
    • Leadership team and Scientific Consultants
    • Strategic Advisory Board (SAB) and Advisors for Commercialization
  • THAC’s pipeline
    • First-in-class drug candidates
    • Promising medical value of THAC drug candidates
    • Publications
  • T2DM pandemics
    • T2DM, a pandemics with still huge unmet medical needs
    • Microbiota, a key role in T2DM
    • Insulin resistance, the root cause of T2DM
  • News
  • Contact us
  • Home

Auteur/autrice : Lyse Santoro

[PRESS RELEASE] Microbiote EN

20210927_THAC_PR_Microbiote_EN_VDEF_Télécharger

[PRESS RELEASE] Microbiote Fr

20210927_THAC_CP_Microbiote_FR_VDEFTélécharger
  • About us
    • About us
    • Board of Directors
    • Leadership team and Scientific Consultants
    • Strategic Advisory Board (SAB) and Advisors for Commercialization
  • THAC’s pipeline
    • First-in-class drug candidates
    • Promising medical value of THAC drug candidates
    • Publications
  • T2DM pandemics
    • T2DM, a pandemics with still huge unmet medical needs
    • Microbiota, a key role in T2DM
    • Insulin resistance, the root cause of T2DM
  • News
  • Contact us
  • Home
  • Partners
  • News

Write us or contact us

  • Incubateur Paris Biotech Santé - 24 rue du Faubourg Saint Jacques, 75014 Paris - USF connect Incubator, 3702 Spectrum Blvd, Tampa, FL 33612, USA
contact@thac.fr Linkedin

THAC France – Incubateur Paris Biotech Santé

Mention légales